Issuu on Google+

Global Epilepsy Market: Industry Analysis & Outlook (2017-2021)

Published: February 2017 Pages: 76 Price: US$ 800 (Single User License)

Order this report by calling +1 888 391 5441 or Send an email to sales@marketreportsonline.com with your contact details and questions if any.


Global Epilepsy Market: Industry Analysis & Outlook (2017-2021)

Epilepsy is a group of neurological diseases characterized by epileptic seizures. Epileptic seizures are episodes that can vary from brief and nearly undetectable to long periods of vigorous shaking. These episodes can result in physical injuries including occasionally broken bones. The medical definition of this disease is as a “condition characterized by recurrent (two or more) epileptic seizures, unprovoked by any immediate identified cause”. Epilepsy is divided into four main types; idiopathic generalized epilepsy, idiopathic partial epilepsy, symptomatic generalized epilepsy and symptomatic partial epilepsy. The cause of epilepsy can be genetic, a result of other disorders such as tumor or brain injury and due to certain seizure triggers. Epilepsy is treated via antiepileptic drugs, surgery in certain cases and several complementary therapies such as ketogenic diets or neural stimulation. Based upon the drug type, epilepsy market can be divided into three main categories; first generation drugs, second generation drugs and third generation drugs. The global epilepsy market is driven by factors such as development of novel drugs, launch of new drugs in developing regions and prevalence of neural disorders such as meningitis and tumors. This growth is then further spearheaded by increasing healthcare expenses and rising disposable incomes. However, the market growth is hindered by tedious drug approval process, generic erosion and high cost of treatment. Trends such as companies focusing on developing effective therapies for refractory epilepsy and physicians demanding higher efficacy drugs are listed in this report. Place a direct purchase order on this “Epilepsy Drugs Market” research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=574913.


Global Epilepsy Market: Industry Analysis & Outlook (2017-2021)

The report “Global Epilepsy Drugs Market: Industry Analysis & Outlook (2017-2021)� analyzes the development of this market, with focus on the Americas, EMEA and APAC regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Novartis AG., Pfizer Inc., GlaxoSmithKline Plc. and UCB are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global epilepsy drugs market along with the study of the regional markets. Few Points from List of Tables: Different Types of Epilepsy Antiepileptic Drugs in Pipeline (2016) New Products of Pfizer with FDA Approval (2015/2016) GlaxoSmithKline Plc. Core R&D Expenditure Allocation (2015) GSK Product Development Pipeline in Pharmaceutical and Vaccine Segment (2015) Explore more pharmaceuticals market research as well as other newly published reports by Koncept Analytics at http://www.marketreportsonline.com/publisher/koncept-analytics-marketresearch.html.

Ultrasound


Global Epilepsy Market: Industry Global Thalassemia Market Report: 2016Analysis Edition& Outlook (2017-2021)

About Us: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us: Ritesh Tiwari 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India Tel: + 1 888 391 5441 E-mail: sales@marketreportsonline.com

http://www.marketreportsonline.com/


Global Epileptic Seizures Market 2017 Analysis